# Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

> **NCT04305548** · PHASE2 · RECRUITING · sponsor: **Italian Sarcoma Group** · enrollment: 16 (estimated)

## Conditions studied

- Mesenchymal Chondrosarcoma

## Interventions

- **DRUG:** Trabectedin

## Key facts

- **NCT ID:** NCT04305548
- **Lead sponsor:** Italian Sarcoma Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-14
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04305548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04305548, "Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04305548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*